MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
CSTL Castle Biosciences
- 27.530
- +0.440+1.62%
Close Dec 20 16:00 ET
- 27.530
- 0.0000.00%
Post 16:13 ET
771.04MMarket Cap131.10P/E (TTM)
27.990High26.580Low382.57KVolume26.580Open27.090Pre Close10.46MTurnover1.41%Turnover RatioLossP/E (Static)28.01MShares35.84052wk High1.75P/B748.69MFloat Cap16.96552wk Low--Dividend TTM27.20MShs Float107.690Historical High--Div YieldTTM5.21%Amplitude9.260Historical Low27.334Avg Price1Lot Size
About Castle Biosciences Company
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, DecisonDx-CMSeq, DecisionDx-SCC, DecsionDx-UMSeq, and DecisonDX-PRAME. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Company Profile
SymbolCSTL
Company NameCastle Biosciences
Listing DateJul 25, 2019
Issue Price16.00
Founded2007
CEOMr. Derek J. Maetzold
MarketNASDAQ
Employees610
Fiscal Year Ends12-31
Address505 South Friendswood Drive,Suite 401
CityFriendswood
ProvinceTexas
CountryUnited States of America
Zip Code77546
Phone1-866-788-9007
Company Executives
- Name
- Position
- Salary
- Derek J. Maetzold
- Director, President and Chief Executive Officer
- 1.61M
- Tobin W. Juvenal
- Chief Commercial Officer
- 829.10K
- Kristen Oelschlager
- Chief Operating Officer
- 828.48K
- Frank Stokes
- Chief Financial Officer and Principal Accounting Officer
- 880.25K
- Daniel M. Bradbury
- Chairman of the Board
- 305.95K
- Rodney Cotton
- Director
- --
- Tiffany P. Olson
- Independent Director
- 279.20K
- Kimberlee S. Caple
- Independent Director
- 276.70K
- Ellen Goldberg
- Independent Director
- 274.20K
- Miles D. Harrison
- Independent Director
- 285.45K
- G. Bradley Cole
- Independent Director
- 289.20K
- Mara Glickman Aspinall
- Independent Director
- 281.70K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.